Skip to main content
Frontiers in Cellular and Infection Microbiology logoLink to Frontiers in Cellular and Infection Microbiology
. 2016 Jan 11;5:102. doi: 10.3389/fcimb.2015.00102

A Systems Biology Approach to Reveal Putative Host-Derived Biomarkers of Periodontitis by Network Topology Characterization of MMP-REDOX/NO and Apoptosis Integrated Pathways

Fares Zeidán-Chuliá 1,2,*, Mervi Gürsoy 2, Ben-Hur Neves de Oliveira 1, Vural Özdemir 3,4,, Eija Könönen 2,5,, Ulvi K Gürsoy 2,
PMCID: PMC4707239  PMID: 26793622

Abstract

Periodontitis, a formidable global health burden, is a common chronic disease that destroys tooth-supporting tissues. Biomarkers of the early phase of this progressive disease are of utmost importance for global health. In this context, saliva represents a non-invasive biosample. By using systems biology tools, we aimed to (1) identify an integrated interactome between matrix metalloproteinase (MMP)-REDOX/nitric oxide (NO) and apoptosis upstream pathways of periodontal inflammation, and (2) characterize the attendant topological network properties to uncover putative biomarkers to be tested in saliva from patients with periodontitis. Hence, we first generated a protein-protein network model of interactions (“BIOMARK” interactome) by using the STRING 10 database, a search tool for the retrieval of interacting genes/proteins, with “Experiments” and “Databases” as input options and a confidence score of 0.400. Second, we determined the centrality values (closeness, stress, degree or connectivity, and betweenness) for the “BIOMARK” members by using the Cytoscape software. We found Ubiquitin C (UBC), Jun proto-oncogene (JUN), and matrix metalloproteinase-14 (MMP14) as the most central hub- and non-hub-bottlenecks among the 211 genes/proteins of the whole interactome. We conclude that UBC, JUN, and MMP14 are likely an optimal candidate group of host-derived biomarkers, in combination with oral pathogenic bacteria-derived proteins, for detecting periodontitis at its early phase by using salivary samples from patients. These findings therefore have broader relevance for systems medicine in global health as well.

Keywords: gelatinases, oxidative stress, saliva, drug target, omics, computational biology, in silico, network

Introduction

Periodontitis is a chronic infection with a progressive inflammatory process of the tooth-supporting tissues and characteristically causes gingival recession, alveolar bone loss, and mobility of the teeth. If the necessary treatment is not performed, this disease can lead to the loss of affected teeth. Several pathways, such as apoptosis, matrix metalloproteinase (MMP)-REDOX/nitric oxide (NO) activation, toll-like receptor, and nuclear factor-kB (NF-kB) signaling, cytokine and chemokine network, complement cascade, and osteoclastogenesis, play a role in the pathogenesis of this chronic disease with remissions and exacerbations (Cekici et al., 2014).

The two host cell types that mainly come across with periodontopathogenic bacteria during inflammation in periodontal tissues are epithelial cells and polymorphonuclear leukocytes (PMNL). The epithelium expresses cytokines, chemokines, proteases, and natural antimicrobial peptides against infectious stimuli (Gursoy and Könönen, 2012). Once bacteria bind to the PMNL surface, phagocytosis results in entrapment of the bacterial cell into a membrane-delimited structure, also known as phagosome. The phagosome undergoes maturation by fusion with endosomes and finally with lysosomes. Lysosomal vesicles include reactive oxygen species (ROS). ROS activate the redox sensitive NF-kB signaling pathway, which induces the expression of cell adhesion receptors, proinflammatory cytokines and chemokines, involved in the production of free radicals and persistence of inflammation (Scott and Krauss, 2012). On one hand, ROS destroy pathogenic bacteria and other phagocytosed material within the safe confines of the phagolysosome. On the other hand, the extracellular release of oxygen intermediates leads to significant destruction in periodontal tissues. This damage is mainly an outcome of elevated MMP activation and increased apoptosis of gingival resident cells (Zeidán-Chuliá et al., 2013, 2014a).

Biomarkers of periodontitis are sorely needed to intervene early in the course of the disease. Periodontitis causes little, if any, discomfort at its initial stages thereby allowing the clinical diagnosis not until alveolar bone loss has already commenced or materialized (Gursoy et al., 2011). Over the past decade, research on salivary diagnostics received attention by virtue of an easy sample access and low cost, while the search for biomarkers broadened in scope to characterize both the human host and resident bacteria using systems science and omics technology (e.g., genomics and/or proteomics) approaches (Cuevas-Córdoba and Santiago-García, 2014; Gürsoy et al., 2014).

It is now widely accepted that periodontitis is a consequence of complex host-environment and biological pathway interactions, rather than a product of a single gene or protein (Hajishengallis and Sahingur, 2014). Network modeling by systems biology-based approaches is increasingly employed as versatile effective tools to unravel the pathogenesis of periodontal disease by integration of multi-omics data (Zhu et al., 2007; Zeidán-Chuliá et al., 2013, 2014a; Gürsoy et al., 2014). Moreover, by studying the topological network properties within an interactome, one might identify nodes (e.g., genes/proteins) with a biologically critical position (bottlenecks) in the overall network architecture and thus putative early disease biomarkers and drug targets. In general, the word “bottleneck” refers to nodes with high betweenness values, indicating that those nodes are central points that control the communication between other nodes within the network. These nodes are “between” highly interconnected subgraph clusters and by removing them, the network could be divided (Yu et al., 2007).

In previous studies, we reported the deregulated expression of apoptosis and MMP-REDOX/NO-related genes in periodontitis samples when compared to those of healthy controls (Zeidán-Chuliá et al., 2013, 2014a). Most common histological findings in early periodontitis are related to neutrophil migration and activation and weakened wound healing in resident cells (Biasi et al., 1999). Neutrophils are one main source of tissue degrading MMPs, while oxidative stress-induced apoptosis of resident cells (gingival epithelia and fibroblasts) is one main outcome of increased bacterial invasion and decreased tissue regeneration (Nussbaum and Shapira, 2011). Therefore, our aims for the present study were (1) to simultaneously analyze these two initial pathways of periodontal inflammation (MMP-REDOX/NO and apoptosis) by systems biology, and (2) to define their functional interconnections as putative biomarkers of early periodontitis.

Materials and methods

Interaction network development, analysis of topological network properties and landscape visualization of centrality values

The “BIOMARK” interactome was developed by using the STRING 10 database (http://string-db.org/; Szklarczyk et al., 2011, 2015) with “Experiments” and “Databases” as input options and a confidence score of 0.400. STRING is a search tool for the retrieval of interacting genes/proteins extracted from diverse curate and public databases with information on direct and indirect functional associations/interactions. Interactions are derived from different sources (1) primary databases, (2) manually-curated databases, (3) Medline abstracts and a large collection of full-text articles, (4) algorithms and co-expression analysis using genomic information, and (5) interactions observed in one organism that are systematically transferred to others via pre-computed orthology relations (Szklarczyk et al., 2015).

As a starting point, we selected two published in silico network models to get the list of genes/proteins that would be part of the interactome (Figure 1): the “MRN” model with MMP and REDOX/NO-related genes/proteins (Zeidán-Chuliá et al., 2013) and the “APOP” model with apoptosis-related genes/proteins (Zeidán-Chuliá et al., 2014a). The criteria to select these models (subnetworks) were based on biological processes typically altered in periodontitis, such as (1) increased production and activity of MMPs by host cells, (2) increased NO production and NOS activity by human oral neutrophils, (3) oxidative stress, as well as (4) increased apoptosis and tissue destruction induced by periodontal pathogens. In silico integration of the two subnetworks onto one interactome would characterize above-mentioned biological processes at the molecular level for the search of potential biomarkers of periodontitis. Thereafter, a Venn diagram was constructed by using the freely available software system R (http://www.r-project.org; Gentleman et al., 2004) in order to visualize the grade of molecular relation (common genes/proteins) between the “MRN” and “APOP” subnetworks. The genes/proteins that integrated the “BIOMARK” interactome were identified by using the Human Genome Organization (HUGO) Gene Symbol (Wain et al., 2004) and Ensembl protein ID (Birney et al., 2006). The selected list (Supplementary Table 1) was applied into the STRING database and the links (interaction strength) between two different nodes (genes/proteins) were saved in data files and handled by utilizing the Cytoscape open source software platform. Cytoscape is used for visualizing complex networks and integrating these with any type of attribute data (Smoot et al., 2011). The original Cys file of “BIOMARK” model is additionally provided as Supplementary Material (Supplementary Data Sheet 1). Topological network properties (Yu et al., 2007) such as closeness, stress, degree or connectivity, and betweenness centralities (Supplementary Table 2) were also analyzed by using the NetworkAnalyzer plugin from the Cytoscape software. Values of centralities above one standard deviation (+1 SD) of the mean were selected to identify potential candidate host-derived biomarker/s.

Figure 1.

Figure 1

Abstract workflow summarizing the criteria and tools used for the present study. The “MRN” and “APOP” in silico models, already available in the literature, were used as the starting material to develop the “BIOMARK” integrating MMP-REDOX/NO and apoptosis related-genes/proteins into one single network of interactions. The Venn diagram, performed by using the software system R, revealed the existence of common nodes (genes/proteins). Thereafter, the interactome was developed for integrating these subnetworks into one single gene/protein interaction network model (“BIOMARK”) by using the STRING 10 and Cytoscape tools. Further elucidation of the topological network properties reveals “vulnerable” points within the in silico model representing candidate diagnostic biomarkers and also potential molecular targets for therapeutics. With GALANT, a Cytoscape plugin, we project numerical data from the topological network properties (centrality measurements) onto “BIOMARK” interactome to create a smoothed data map resembling the network layout. Central members of “BIOMARK,” easily detectable in saliva, represent optimal candidates to be tested as periodontitis biomarkers.

Of note, closeness measures the grade of proximity of a node to the rest of nodes. The larger the value, the faster the information spreads through this node. Stress measures the number of times a given node is traversed by ideal routes or “shortest paths” within a network. Nodes that are traversed by higher numbers of short paths are by definition more stressed. Degree measures the local topology of each node by summing up the number of its adjacent nodes. Nodes with high values of degree over the thresholds values are named as “hubs.” Betweenness, which is similar to stress as a topological network property, measures how frequently the shortest path, connecting every pair of nodes, is going through a third given node. Therefore, both stress and betweenness provide information about the influence of a node over the spread of information throughout the interactome. All nodes with high values of betweenness over the thresholds values were named as “bottlenecks” (non-hub- and hub-bottlenecks are represented by NH-B and HB, respectively).

For the network-level visualization of centrality values in the “BIOMARK” interactome, we utilized GALANT (GrAph LANdscape VisualizaTion). GALANT is a Cytoscape plugin that builds functional landscapes onto biological networks (Camilo et al., 2013). GALANT projects any kind of numerical data (e.g., centrality measurements) onto a network in order to create landscapes resembling the network layout, and also offers a friendly interface fully integrated with the Cytoscape where users can easily build their landscapes of interest by using one of the previously mentioned functions.

Results

“BIOMARK” is an integrative network model for MMP-REDOX/NO and apoptosis subnetworks

Two previously published subnetworks of gene/protein interactions characterizing the molecular landscape of MMP-REDOX/NO (“MRN”) and apoptosis (“APOP”) pathways were selected (Figure 1). The Venn diagram, which visualizes the level of subnetwork information integration, shows that both subnetworks contain five common nodes (genes/proteins) allowing communication with one another for constructing the “BIOMARK” interactome (Figure 2). In the case of non-existing direct crosstalk through common subnetwork nodes, it is possible to find common neighboring nodes (genes/proteins) to members of both subnetworks by the use of mathematical algorithms in the R environment. By using the STRING 10 (“Experiments” and “Databases”; confidence score of 0.400) and plotting with the Cytoscape software, we then developed the in silico network model “BIOMARK” (Figure 3) composed of 211 genes/proteins interconnecting through 1634 interactions.

Figure 2.

Figure 2

Venn diagram showing information integration from the studied subnetworks. The “MRN” (MMP-REDOX/NO) and “APOP” (apoptosis) network models contain five common nodes (genes/proteins).

Figure 3.

Figure 3

“BIOMARK” interactome. The network model of interactions between genes/protein belonging to “MRN” (MMP-REDOX/NO) and “APOP” (apoptosis) subnetworks or “BIOMARK” interactome was developed by using the STRING 10 database resource search tool, under a confidence score of 0.400, and by using “Databases” and “Experiments” as input options and visualized by plotting it with Cytoscape software. The subnetwork contribution of each gene/protein within the network is represented in the figure with blue-colored (MMP-REDOX/NO), yellow-colored (apoptosis), or green-colored nodes (contributing to both MMP-REDOX/NO and apoptosis subnetworks).

Identification of three key hub genes/proteins within the “BIOMARK” interactome suggests UBC, JUN, and MMP14 as putative host-derived biomarkers of periodontitis

For describing the global characteristics of the newly-developed interactome, we elucidated the topological network properties or centrality values (Supplementary Table 2). The measurements uncover the most central nodes (genes/proteins) of our model, representing “vulnerable” points within the “BIOMARK” interactome. Central genes/proteins can be thus considered putative biomarkers, because variations in these members can trigger more intense changes in the rest of the interactome than those in non- or less central members. After calculating each centrality value for the 211 “BIOMARK” gene/protein members and visualizing the data as a functional landscape projected onto the interactome, we identified network areas with high centrality values and, more specifically, Ubiquitin C (UBC) and Jun proto-oncogene (JUN) as hub-bottlenecks (HBs) of our model (Figure 4 and Table 1). These genes/proteins also displayed the highest values of stress and closeness centralities. Moreover, only a third gene/protein, MMP14 (an activator of host gelatinases), was identified as non-hub-bottleneck (NH-B) with a betweenness value over the threshold (Figure 5 and Table 1).

Figure 4.

Figure 4

GALANT plots of centrality values over the “BIOMARK” interactome. Analysis of the topological network properties by Cytoscape and its 2D projection by the GALANT software over the “BIOMARK” interactome (A) show the areas of maximum values (red color) of stress (B), betweenness (C), degree (D), and closeness centralities (E) of each node in this color-grading representation.

Table 1.

Nodes (genes/proteins) with the highest betweenness values from the “BIOMARK” interactome that integrates MMP-REDOX/NO (“MRN”) and apoptosis (“APOP”) subnetworks.

NAME/SYMBOL —/HB/NH-B Closeness Stress Degree Betweenness
UBC HB 0.74204947 111,970 146 0.50695465
JUN HB 0.53571429 17,440 45 0.04948189
MMP14 NH-B 0.47727273 10,116 18 0.04427346
TP53 0.53164557 12,626 50 0.03929094
MMP2 0.42510121 10,940 24 0.03761779
MYB 0.47191011 5590 17 0.02991401
MMP9 0.41666667 10,146 24 0.02747875
RELA 0.52369077 10,756 47 0.02417225
EP300 0.52631579 8960 48 0.01898303
DFFB 0.43659044 2568 4 0.01857965
APP 0.48498845 4704 25 0.01581576
NFKB1 0.5060241 7870 38 0.01551606
CASP3 0.48387097 5000 34 0.01418542
TIMP1 0.47511312 3998 14 0.01402902
CHUK 0.50724638 7092 47 0.01394735
AKT1 0.49065421 5388 34 0.01363533
DCN 0.37366548 2994 8 0.01291272
MAP3K5 0.47619048 3706 27 0.01285955
TRAF2 0.48498845 4716 28 0.01225608
IKBKB 0.5060241 5976 44 0.01139259
Average 0.4278415 2297.54 15.583 0.006697052
+1 SD 0.492552 10277.8 29.4 0.042061202
+2 SD 0.5572626 18,258 43.217 0.077425351

Closeness, stress, and degree values are also shown. Centralities over the thresholds with value/s above one (+1 SD) or two (+2 SD) standard deviations of the mean are color-marked. Nodes identified as non-hub-bottlenecks and hub-bottlenecks (based on degree and betweenness centralities), with values above +1 SD of the mean, are represented as NH-B and HB, respectively.

Figure 5.

Figure 5

Analysis of the topological properties (betweenness vs. degree) of genes/proteins belonging to the “BIOMARK” interactome. Blue and red lines indicate the threshold value for each property or value/s above one (+1 SD, blue color) or two (+2 SD, red color) standard deviations of the mean. In the graphs, genes/proteins are represented by circles and plotted in blue or red when value/s fall within +1 or +2 SD, respectively. Values of centralities above +1 SD of the mean were selected to identify potential candidate host-derived biomarker/s.

Discussion

In the present study, our principal aim was to test the feasibility of creating an in silico model able to provide a molecular landscape of putative salivary biomarkers of periodontitis that could be later analyzed by wet laboratory techniques from patient samples. This model should be able to integrate a maximum number of genes/proteins from biological processes that are typically altered in periodontal inflammation (e.g., oxidative stress and apoptosis) into one single interactome.

According to our results, UBC, JUN, and MMP14 control the flow of biological information within the interactome integrating the MMP-REDOX/NO and apoptosis pathways. Their up- or down-regulation would critically affect the entire network, since they are the most central proteins of the “BIOMARK” interactome in comparison to the rest of network members. In a similar manner, if UBC, JUN, or MMP14 is disrupted by drug interaction, the entire network would be destroyed into small components. Thus, they represent three optimal therapeutic targets in silico, to be tested in vitro and/or in vivo. By applying the same criteria, the cumulative use of JUN, UBC, and MMP14 together with oral pathogenic bacteria-derived proteins (Gursoy et al., 2011) could be used as representative biomarkers of susceptibility to periodontitis for early intervention, if these central members are detectable in saliva from diseased individuals at the RNA or protein level (Kousvelari et al., 1990; Fábián et al., 2008; Cuevas-Córdoba and Santiago-García, 2014; Rall et al., 2015). UBC is a highly connected protein in the whole human protein-protein interaction network and it is involved in pathogenesis of different diseases (e.g., neurodegenerative diseases; Ullrich et al., 2010). Its use for the diagnosis of periodontitis may lack sensitivity and this could be considered as a potential limitation.

As a general conceptual framework, protein-protein interactions offer the opportunity to analyze the functional relationships among biological molecules (Gursoy et al., 2008). The more processes are integrated in the form of subnetworks in the interactome, the more accurate will our in silico model be to reflect the molecular pathogenesis of periodontal inflammation. An alternative possibility is, however, that other markers could also act as central members over the threshold upon the integration of additional subnetworks in the model, representing deregulated biological processes in periodontitis (e.g., epithelial cell adhesion; Haapasalmi et al., 1995; Gürsoy et al., 2015). These newly developed subnetworks might also be considered in the future as part of a systems biology approach utilized in different fields of medicine such as cancer, neurodegenerative, and psychiatric diseases (Rosado et al., 2011; Santana-Codina et al., 2013; ElRakaiby et al., 2014; Podder and Latha, 2014; Zeidán-Chuliá et al., 2014b; Ebhardt et al., 2015).

Saliva has a major importance in the maintenance of oral health, and, during the past two decades, it has been considered a potential specimen to detect oral and systemic diseases (Ji and Choi, 2015). Specific biomarkers have been identified from saliva, reflecting the three key features of pathogenic processes in periodontal disease, i.e., infection-induced inflammation, collagen degradation, and bone turnover (Zhang et al., 2009). Host- and bacteria-derived enzymes, proteins, and other inflammatory mediators appear to hold great promise as salivary biomarkers for the diagnosis of periodontal disease (Ramseier et al., 2009; Haigh et al., 2010; Salazar et al., 2013).

Saliva represents a non-invasive and safe study specimen, being especially useful in large-scale studies. During the onset and progress of periodontitis, inflammatory markers are released from cells present in the periodontium. Elevated levels of enzymes, cytokines, and biomarkers of connective tissue destruction and bone turnover can be found in saliva of periodontitis patients in comparison to their controls (Gursoy et al., 2009, 2010, 2013; Kinney et al., 2011; Lee et al., 2012). Furthermore, there is a considerable interest in applying sequencing and genotyping studies in various human populations. It has been demonstrated that saliva samples, in comparison to cheek swabs, provide a substantial increase in the amount of human DNA (Fábián et al., 2008). Although saliva may be used as a diagnostic tool for detecting periodontitis, there is only a subtle consensus on few salivary molecules to be used as putative markers of periodontitis (Gursoy et al., 2011; Salminen et al., 2014). The search for a novel biomarker is a costly and long-term process. With the aid of systems biology, however, it is possible to simultaneously analyze multiple candidate biomarkers within a network of interactions representing different biological processes (e.g., apoptosis, oxidative stress, and MMP secretion), which are characteristic of a given disease, such as periodontitis.

Up to our knowledge, our study is the first one combining MMP-REDOX/NO and apoptosis pathways that are well-known pathways in inflammatory diseases, including periodontitis, in an attempt to find regulative biomarkers. These two pathways that represent diminished tissue regeneration were taken as an example, since periodontitis is an outcome of a disrupted balance between tissue degeneration and regeneration. The selected pathways, however, form only a part of the whole cascade of events, and applying other additional models may give different results. Therefore, testing different underlying mechanisms in a combined manner would be beneficial to design putative biomarker groups for periodontitis.

In general, pathogenic pathways involved in the imbalance of connective tissue homeostasis in periodontitis are complex. Regarding our proposed candidate biomarkers, polyubiquitin-C is known as a precursor protein encoded by the UBC gene that is cleaved into the active ubiquitin monomer (Hanna et al., 2007). Among other processes, the ubiquitin conjugation system regulates protein degradation and signal transduction, playing a critical role in the regulation of innate and adaptive immunological responses (Liu et al., 2005). It seems that a decreased ubiquitin level can reduce the activation threshold of cells to environmental stressors, and UBC has been thus proposed as one promising candidate biomarker together with calmodulin-like protein 5 for the identification of newborns predisposed to develop atopic eczema (Holm et al., 2014). The Jun proto-oncogene (JUN) is a component of the AP-1 transcription factor, which is activated by several extracellular stimuli, such as proinflammatory cytokines and UV radiation, and plays a role in mediating the cellular response (Wisdom et al., 1999). For instance, c-Jun confers protection against UV-induced cellular apoptosis (Wisdom et al., 1999). It was recently shown that several genes involved in cellular apoptosis are deregulated in diseased gingival samples from periodontitis patients (Zeidán-Chuliá et al., 2014a). In fibroblasts, c-Jun has been suggested to activate cell death by acting as a transcriptional regulator (Bossy-Wetzel et al., 1997), likely having a similar role in periodontal inflammation. Finally, it is well-known that MMP14 is able to degrade collagen and gelatin, activate other MMPs relevant in periodontal inflammation progression, such as MMP2 and MMP13, shed cell surface proteins, and prevent collagen-induced apoptosis (Maquoi et al., 2012; Albrechtsen et al., 2013; Zeidán-Chuliá et al., 2013). To the best of our knowledge, there are no previous data reporting UBC and JUN as putative biomarkers of periodontitis. Our study group has previously analyzed salivary MMP14 concentrations as a potential biomarker for advanced periodontitis but failed to show any significant difference between periodontitis and non-periodontitis/gingivitis subjects (Gursoy et al., 2010). Instead, as an activator of main collagen degrading enzymes of gingiva like MMP2 and MMP9, which are known to be up-regulated in periodontitis (Zeidán-Chuliá et al., 2013; Haage et al., 2014), MMP14 may be a potential marker of inflammatory processes at early phases of periodontal pathogenesis.

On the basis of our findings, we propose the cumulative use of UBC, JUN, and MMP14, possibly in combination with oral pathogenic bacteria-derived proteins, as putative biomarkers for early detection of periodontitis to be tested either at the RNA or protein level in salivary samples. For example, high-throughput omics data found in other publicly available databases (e.g., Gene Expression Omnibus, Reactome, or BioGRID) could be used to validate our candidate biomarkers or further expand the BIOMARK interactome. Besides, the present systems biology-based approach may be used as an objective tool to identify, with measurable parameters, candidate molecular targets to treat this disease.

Author contributions

FZ and UG conceived of the study; FZ, UK, EK, VO, and MG participated in its design and coordination; FZ and BN performed the in silico analyses; FZ and UG wrote the manuscript; EK, VO, and MG provided the critical revision of the manuscript; all authors read and approved the final manuscript.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

Fares Zeidán-Chuliá holds a PNPD postdoctoral position (Programa de Pós-Graduação em Ciências Biológicas: Bioquímica, Departamento de Bioquímica, Universidade Federal do Rio Grande do Sul) funded by CAPES.

Supplementary material

The Supplementary Material for this article can be found online at: http://journal.frontiersin.org/article/10.3389/fcimb.2015.00102

References

  1. Albrechtsen R., Kveiborg M., Stautz D., Vikeså J., Noer J. B., Kotzsh A., et al. (2013). ADAM12 redistributes and activates MMP-14, resulting in gelatin degradation, reduced apoptosis and increased tumor growth. J. Cell Sci. 126, 4707–4720. 10.1242/jcs.129510 [DOI] [PubMed] [Google Scholar]
  2. Biasi D., Bambara L. M., Carletto A., Caramaschi P., Andrioli G., Urbani G., et al. (1999). Neutrophil migration, oxidative metabolism and adhesion in early onset periodontitis. J. Clin. Periodontol. 26, 563–568. 10.1034/j.1600-051X.1999.260901.x [DOI] [PubMed] [Google Scholar]
  3. Birney E., Andrews D., Caccamo M., Chen Y., Clarke L., Coates G., et al. (2006). Ensembl 2006. Nucleic Acids Res. 34, 556–561. 10.1093/nar/gkj133 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bossy-Wetzel E., Bakiri L., Yaniv M. (1997). Induction of apoptosis by the transcription factor c-Jun. EMBO J. 16, 1695–1709. 10.1093/emboj/16.7.1695 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cekici A., Kantarci A., Hasturk H., Van Dyke T. E. (2014). Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol. 2000 64, 57–80. 10.1111/prd.12002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cuevas-Córdoba B., Santiago-García J. (2014). Saliva: a fluid of study for OMICS. OMICS 18, 87–97. 10.1089/omi.2013.0064 [DOI] [PubMed] [Google Scholar]
  7. Camilo E., Bovolenta L. A., Acencio M. L., Rybarczyk-Filho J. L., Castro M. A., Moreira J. C., et al. (2013). GALANT: a Cytoscape plugin for visualizing data as functional landscapes projected onto biological networks. Bioinformatics 29, 2505–2506. 10.1093/bioinformatics/btt377 [DOI] [PubMed] [Google Scholar]
  8. Ebhardt H. A., Root A., Sander C., Aebersold R. (2015). Applications of targeted proteomics in systems biology and translational medicine. Proteomics 15, 3193–3208. 10.1002/pmic.201500004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. ElRakaiby M., Dutilh B. E., Rizkallah M. R., Boleij A., Cole J. N., Aziz R. K. (2014). Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. OMICS 18, 402–414. 10.1089/omi.2014.0018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fábián T. K., Fejérdy P., Csermely P. (2008). Salivary Genomics, transcriptomics and proteomics: the emerging concept of the oral ecosystem and their use in the early diagnosis of cancer and other diseases. Curr. Genomics 9, 11–21. 10.2174/138920208783884900 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gentleman R. C., Carey V. J., Bates D. M., Bolstad B., Dettling M., Dudoit S., et al. (2004). Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80. 10.1186/gb-2004-5-10-r80 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gursoy A., Keskin O., Nussinov R. (2008). Topological properties of protein interaction networks from a structural perspective. Biochem. Soc. Trans. 36, 1398–1403. 10.1042/BST0361398 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gürsoy M., Zeidán-Chuliá F., Könönen E., Moreira J. C., Liukkonen J., Sorsa T., et al. (2014). Pregnancy-induced gingivitis and OMICS in dentistry: in silico modeling and in vivo prospective validation of estradiol-modulated inflammatory biomarkers. OMICS 18, 582–590. 10.1089/omi.2014.0020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gursoy U. K., Könönen E. (2012). Understanding the roles of gingival beta-defensins. J. Oral Microbiol. 4. 10.3402/jom.v4i0.15127 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gursoy U. K., Könönen E., Huumonen S., Tervahartiala T., Pussinen P. J., Suominen A. L., et al. (2013). Salivary type I collagen degradation end-products and related matrix metalloproteinases in periodontitis. J. Clin. Periodontol. 40, 18–25. 10.1111/jcpe.12020 [DOI] [PubMed] [Google Scholar]
  16. Gursoy U. K., Könönen E., Pradhan-Palikhe P., Tervahartiala T., Pussinen P. J., Suominen-Taipale L., et al. (2010). Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis. J. Clin. Periodontol. 37, 487–493. 10.1111/j.1600-051X.2010.01563.x [DOI] [PubMed] [Google Scholar]
  17. Gursoy U. K., Könönen E., Pussinen P. J., Tervahartiala T., Hyvärinen K., Suominen A. L., et al. (2011). Use of host- and bacteria-derived salivary markers in detection of periodontitis: a cumulative approach. Dis. Markers. 30, 299–305. 10.1155/2011/621484 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gursoy U. K., Könönen E., Uitto V. J., Pussinen P. J., Hyvärinen K., Suominen-Taipale L., et al. (2009). Salivary interleukin-1beta concentration and the presence of multiple pathogens in periodontitis. J. Clin. Periodontol. 36, 922–927. 10.1111/j.1600-051X.2009.01480.x [DOI] [PubMed] [Google Scholar]
  19. Gürsoy U. K., Zeidán-Chuliá F., Yilmaz D., Özdemir V., Mäki-Petäys J., de Oliveira B. N., et al. (2015). Analyses of Gingival Adhesion Molecules in periodontitis: theoretical in silico, comparative in vivo, and explanatory in vitro models. J. Periodontol. 10.1902/jop.2015.150361. [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  20. Haage A., Nam D. H., Ge X., Schneider I. C. (2014). Matrix metalloproteinase-14 is a mechanically regulated activator of secreted MMPs and invasion. Biochem. Biophys. Res. Commun. 450, 213–218. 10.1016/j.bbrc.2014.05.086 [DOI] [PubMed] [Google Scholar]
  21. Haapasalmi K., Mäkelä M., Oksala O., Heino J., Yamada K. M., Uitto V. J., et al. (1995). Expression of epithelial adhesion proteins and integrins in chronic inflammation. Am. J. Pathol. 147, 193–206. [PMC free article] [PubMed] [Google Scholar]
  22. Haigh B. J., Stewart K. W., Whelan J. R., Barnett M. P., Smolenski G. A., Wheeler T. T. (2010). Alterations in the salivary proteome associated with periodontitis. J. Clin. Periodontol. 37, 241–247. 10.1111/j.1600-051X.2009.01525.x [DOI] [PubMed] [Google Scholar]
  23. Hajishengallis G., Sahingur S. E. (2014). Novel inflammatory pathways in periodontitis. Adv. Dent. Res. 26, 23–29. 10.1177/0022034514526240 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hanna J., Meides A., Zhang D. P., Finley D. (2007). A ubiquitin stress response induces altered proteasome composition. Cell 129, 747–759. 10.1016/j.cell.2007.03.042 [DOI] [PubMed] [Google Scholar]
  25. Holm T., Rutishauser D., Kai-Larsen Y., Lyutvinskiy Y., Stenius F., Zubarev R. A., et al. (2014). Protein biomarkers in vernix with potential to predict the development of atopic eczema in early childhood. Allergy 69, 104–112. 10.1111/all.12308 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ji S., Choi Y. (2015). Point-of-care diagnosis of periodontitis using saliva: technically feasible but still a challenge. Front. Cell. Infect. Microbiol. 5:65. 10.3389/fcimb.2015.00065 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kinney J. S., Morelli T., Braun T., Ramseier C. A., Herr A. E., Sugai J. V., et al. (2011). Saliva/pathogen biomarker signatures and periodontal disease progression. J. Dent. Res. 90, 752–758. 10.1177/0022034511399908 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kousvelari E., Yeh C. K., Mertz P. M., Chinchetru M. (1990). Regulation of proto-oncogenes and salivary gland cell proliferation. Adv. Dent. Res. 4, 61–68. [DOI] [PubMed] [Google Scholar]
  29. Lee A., Ghaname C. B., Braun T. M., Sugai J. V., Teles R. P., Loesche W. J., et al. (2012). Bacterial and salivary biomarkers predict the gingival inflammatory profile. J. Periodontol. 83, 79–89. 10.1902/jop.2011.110060 [DOI] [PubMed] [Google Scholar]
  30. Liu Y. C., Penninger J., Karin M. (2005). Immunity by ubiquitylation: a reversible process of modification. Nat. Rev. Immunol. 5, 941–952. 10.1038/nri1731 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Maquoi E., Assent D., Detilleux J., Pequeux C., Foidart J. M., Noël A. (2012). MT1-MMP protects breast carcinoma cells against type I collagen-induced apoptosis. Oncogene 31, 480–493. 10.1038/onc.2011.249 [DOI] [PubMed] [Google Scholar]
  32. Nussbaum G., Shapira L. (2011). How has neutrophil research improved our understanding of periodontal pathogenesis? J. Clin. Periodontol. 38, 49–59. 10.1111/j.1600-051X.2010.01678.x [DOI] [PubMed] [Google Scholar]
  33. Podder A., Latha N. (2014). New insights into schizophrenia disease genes interactome in the human brain: emerging targets and therapeutic implications in the postgenomics era. OMICS 18, 754–766. 10.1089/omi.2014.0082 [DOI] [PubMed] [Google Scholar]
  34. Rall K., Eisenbeis S., Barresi G., Rückner D., Walter M., Poths S., et al. (2015). Mayer-Rokitansky-Küster-Hauser syndrome discordance in monozygotic twins: matrix metalloproteinase 14, low-density lipoprotein receptor-related protein 10, extracellular matrix, and neoangiogenesis genes identified as candidate genes in a tissue-specific mosaicism. Fertil. Steril. 103, 494–502. 10.1016/j.fertnstert.2014.10.053 [DOI] [PubMed] [Google Scholar]
  35. Ramseier C. A., Kinney J. S., Herr A. E., Braun T., Sugai J. V., Shelburne C. A., et al. (2009). Identification of pathogen and host-response markers correlated with periodontal disease. J. Periodontol. 80, 436–446. 10.1902/jop.2009.080480 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rosado J. O., Henriques J. P., Bonatto D. (2011). A systems pharmacology analysis of major chemotherapy combination regimens used in gastric cancer treatment: predicting potential new protein targets and drugs. Curr. Cancer Drug Targets 11, 849–869. 10.2174/156800911796798977 [DOI] [PubMed] [Google Scholar]
  37. Salazar M. G., Jehmlich N., Murr A., Dhople V. M., Holtfreter B., Hammer E., et al. (2013). Identification of periodontitis associated changes in the proteome of whole human saliva by mass spectrometric analysis. J. Clin. Periodontol. 40, 825–832. 10.1111/jcpe.12130 [DOI] [PubMed] [Google Scholar]
  38. Salminen A., Gursoy U. K., Paju S., Hyvärinen K., Mäntylä P., Buhlin K., et al. (2014). Salivary biomarkers of bacterial burden, inflammatory response, and tissue destruction in periodontitis. J. Clin. Periodontol. 41, 442–450. 10.1111/jcpe.12234 [DOI] [PubMed] [Google Scholar]
  39. Santana-Codina N., Carretero R., Sanz-Pamplona R., Cabrera T., Guney E., Oliva B., et al. (2013). A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasis. Mol. Cell. Proteomics 12, 2111–2125. 10.1074/mcp.M112.022772 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Scott D. A., Krauss J. (2012). Neutrophils in periodontal inflammation. Front. Oral Biol. 15, 56–83. 10.1159/000329672 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Smoot M. E., Ono K., Ruscheinski J., Wang P. L., Ideker T. (2011). Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27, 431–432. 10.1093/bioinformatics/btq675 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Szklarczyk D., Franceschini A., Kuhn M., Simonovic M., Roth A., Minguez P., et al. (2011). The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39, 561–568. 10.1093/nar/gkq973 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Szklarczyk D., Franceschini A., Wyder S., Forslund K., Heller D., Huerta-Cepas J., et al. (2015). STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43, 447–452. 10.1093/nar/gku1003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Ullrich C., Mlekusch R., Kuschnig A., Marksteiner J., Humpel C. (2010). Ubiquitin enzymes, ubiquitin and proteasome activity in blood mononuclear cells of MCI, Alzheimer and Parkinson patients. Curr. Alzheimer Res. 7, 549–555. 10.2174/156720510792231766 [DOI] [PubMed] [Google Scholar]
  45. Wain H. M., Lush M. J., Ducluzeau F., Khodiyar V. K., Povey S. (2004). Genew: the human gene nomenclature database, 2004 updates. Nucleic Acids Res. 32, 255–257. 10.1093/nar/gkh072 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Wisdom R., Johnson R. S., Moore C. (1999). c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 18, 188–197. 10.1093/emboj/18.1.188 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Yu H., Kim P. M., Sprecher E., Trifonov V., Gerstein M. (2007). The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput. Biol. 3:e59. 10.1371/journal.pcbi.0030059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Zeidán-Chuliá F., de Oliveira B. H., Salmina A. B., Casanova M. F., Gelain D. P., Noda M., et al. (2014b). Altered expression of Alzheimer's disease-related genes in the cerebellum of autistic patients: a model for disrupted brain connectome and therapy. Cell Death Dis. 5, e1250. 10.1038/cddis.2014.227 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Zeidán-Chuliá F., Gursoy M., de Oliveira B. H., Gelain D. P., Könönen E., Gursoy U. K., et al. (2014a). Focussed microarray analysis of apoptosis in periodontitis and its potential pharmacological targeting by carvacrol. Arch. Oral Biol. 59, 461–469. 10.1016/j.archoralbio.2014.01.007 [DOI] [PubMed] [Google Scholar]
  50. Zeidán-Chuliá F., Neves de Oliveira B. H., Gursoy M., Könönen E., Fonseca Moreira J. C., Gursoy U. K., et al. (2013). MMP-REDOX/NO interplay in periodontitis and its inhibition with Satureja hortensis L. essential oil. Chem. Biodivers. 10, 507–523. 10.1002/cbdv.201200375 [DOI] [PubMed] [Google Scholar]
  51. Zhang L., Henson B. S., Camargo P. M., Wong D. T. (2009). The clinical value of salivary biomarkers for periodontal disease. Periodontol. 2000 51, 25–37. 10.1111/j.1600-0757.2009.00315.x [DOI] [PubMed] [Google Scholar]
  52. Zhu X., Gerstein M., Snyder M. (2007). Getting connected: analysis and principles of biological networks. Genes Dev. 21, 1010–1024. 10.1101/gad.1528707 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Frontiers in Cellular and Infection Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES